Sodium Bicarbonate in 5% Dextrose Injection — Class I drug recall D-0767-2021
Terminated recall by SterRx, LLC, reported 2021-09-01, distributed nationwide. Non-Sterility: firm's third party lab confirmed microbial contamination.
| Recall number | D-0767-2021 |
|---|---|
| Product type | Drug |
| Classification | Class I |
| Status | Terminated |
| Voluntary or mandated | Voluntary |
| Recalling firm | SterRx, LLC, Plattsburgh, NY, United States |
| Recall initiated | 2021-08-10 |
| Classified | 2021-08-25 |
| Reported by FDA | 2021-09-01 |
| Terminated | 2022-05-19 |
| Distributed | Nationwide (US) |
| Quantity | 1,098 bags |
| Reason classes | microbial contamination, sterility |
| NDC | 70324-0326-01 |
| Expiration dates | 2022-03-23 |
Product
Sodium Bicarbonate in 5% Dextrose Injection, 150 mEq per 1,000 mL (12.6 mg per mL), 1,000 mL bags, Rx only, SterRx, 141 Idaho Ave., Plattsburgh, NY 12903 NDC 70324-326-01
Reason for recall
Non-Sterility: firm's third party lab confirmed microbial contamination.
Machine access
This record, with every extracted code, the verbatim FDA record and provenance, is available from the recall API: GET https://api.data.aroqon.com/v1/recalls/D-0767-2021. Look up any UPC, UDI, NDC or lot with /v1/recalls/lookup?code=…. API docs · free and paid keys.
Source: U.S. Food and Drug Administration enforcement report via openFDA (CC0). Structured by Data Foundry (recall-structuring@2); last changed 2026-09-26. Not affiliated with or endorsed by FDA. Not medical or legal advice.